Global Medical Cannabis Market 2022-2028

August 2022 | 80 pages | ID: G59AFBFF324BEN
Gen Consulting Company

Abstracts

The global medical cannabis market is anticipated to increase by USD 6 billion till 2028 at an average annual growth of 9.8 percent as per the latest report by Gen Consulting Company.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global medical cannabis market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the medical cannabis industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, derivative, route of administration, application, distribution channel, and region. The global market for medical cannabis can be segmented by product: dissolvables and powders, oils, ointments and creams, solids. In 2021, the dissolvables and powders segment made up the largest share of revenue generated by the medical cannabis market. Medical cannabis market is further segmented by derivative: cannabidiol, tetrahydrocannabinol. Based on route of administration, the medical cannabis market is segmented into: inhalation, oral, topical. On the basis of application, the medical cannabis market also can be divided into: management of neurological disorders, mental health, pain management. Medical cannabis market by distribution channel is categorized into: hospitals, online pharmacies, pharmacies. The medical cannabis market by region can be segmented into: North America, Europe, Asia-Pacific, Rest of the World.

By product:

• dissolvables and powders
• oils
• ointments and creams
• solids

By derivative:

• cannabidiol
• tetrahydrocannabinol

By route of administration:

• inhalation
• oral
• topical

By application:

• management of neurological disorders
• mental health
• pain management

By distribution channel:

• hospitals
• online pharmacies
• pharmacies

By region:

• North America
• Europe
• Asia-Pacific
• Rest of the World

The report also provides analysis of the key companies of the industry and their detailed company profiles including Aurora Cannabis Inc., Cannabis Sativa, Inc., Canopy Growth Corporation, Cara Therapeutics, Inc., Emerald Health Therapeutics, Inc., GB Sciences, Inc., GW Pharmaceuticals plc, InterCure Ltd., Medical Marijuana, Inc., Tilray Brands, Inc., among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report

• To analyze and forecast the market size of the global medical cannabis market.
• To classify and forecast the global medical cannabis market based on product, derivative, route of administration, application, distribution channel, region.
• To identify drivers and challenges for the global medical cannabis market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global medical cannabis market.
• To identify and analyze the profile of leading players operating in the global medical cannabis market.

Why Choose This Report

• Gain a reliable outlook of the global medical cannabis market forecasts from 2022 to 2028 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience

PART 2. METHODOLOGY

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

Introduction
Drivers
Restraints
Impact of COVID-19 pandemic

PART 5. MARKET BREAKDOWN BY PRODUCT

Dissolvables and powders
Oils
Ointments and creams
Solids

PART 6. MARKET BREAKDOWN BY DERIVATIVE

Cannabidiol
Tetrahydrocannabinol

PART 7. MARKET BREAKDOWN BY ROUTE OF ADMINISTRATION

Inhalation
Oral
Topical

PART 8. MARKET BREAKDOWN BY APPLICATION

Management of neurological disorders
Mental health
Pain management

PART 9. MARKET BREAKDOWN BY DISTRIBUTION CHANNEL

Hospitals
Online pharmacies
Pharmacies

PART 10. MARKET BREAKDOWN BY REGION

North America
Europe
Asia-Pacific
Rest of the World

PART 11. KEY COMPANIES

Aurora Cannabis Inc.
Cannabis Sativa, Inc.
Canopy Growth Corporation
Cara Therapeutics, Inc.
Emerald Health Therapeutics, Inc.
GB Sciences, Inc.
GW Pharmaceuticals plc
InterCure Ltd.
Medical Marijuana, Inc.
Tilray Brands, Inc.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER